Home About ISR Investor Relations Media Room

Press release 2017-04-28

ISR presenterar kliniska fas IIa data på internationellt möte i USA

Files & documents

ISR pressmeddelande 28 april 2017 (PDF)

Previous Next

Twitter ISR on Nasdaq

© ISR Immune System Regulation Holding AB (publ). All rights reserved.

Retzius väg 11

SE-171 65 Solna, Sweden

Email: info@israb.se

Phone: +46 705 42 79 39